Cannabis study aims to unlock immune secrets in HIV patients
NCT ID NCT06034314
First seen Nov 05, 2025 · Last updated May 23, 2026 · Updated 21 times
Summary
This study looks at how cannabis (specifically the drug Dronabinol) affects the immune system and genes in people with HIV. Researchers will take blood samples before and after giving Dronabinol to see changes in immune cells and inflammation. The goal is to better understand these effects, which could help shape public health policies and guide future treatments. About 160 adults with HIV who use or have used cannabis will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Connecticut Mental Health Center
New Haven, Connecticut, 06511, United States
Conditions
Explore the condition pages connected to this study.